Form 4 filed by Quinlan Paul T
Quinlan Paul T filed this Form 4 on ORKA (Oruka Therapeutics, Inc.) with 7 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-21 00:42:22 UTC.
- Accession
- 0000907654-26-000110
- Filer
- CIK 1333277
- Filed
- 2026-10-20
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ORKA · Oruka Therapeutics, Inc. (CIK 907654)
- Quinlan Paul T officer (General Counsel)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-20 | M exercised | +9,000 | $7.8 | 38,995 | D |
| Common Stock | 2026-10-20 | S sold | -400 | $74.9007 | 38,595 | D |
| Common Stock | 2026-10-20 | S sold | -500 | $76.118 | 38,095 | D |
| Common Stock | 2026-10-20 | S sold | -1,000 | $77.205 | 37,095 | D |
| Common Stock | 2026-10-20 | S sold | -4,100 | $78.7895 | 32,995 | D |
| Common Stock | 2026-10-20 | S sold | -3,000 | $79.4912 | 29,995 | D |
| Employee Warrant (right to buy) derivative | 2026-10-20 | M exercised | -9,000 | $0 | 70,996 | D |